Postpartum blood sugar screening after gestational diabetes
Official title: Strategies for Improving the Detection of Dysglycemia in the Postpartum Period in Women With Gestational Diabetes: Electronic Reminders and New Diagnostic Criteria
Run by University of Sao Paulo General Hospital · NCT07489456 · Data updated 2026-11-12
This study will test whether WhatsApp reminders help women who had gestational diabetes attend a 75g OGTT at 6–12 weeks postpartum and whether the 1-hour glucose measure detects more cases of dysglycemia than the 2-hour measure.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | Women only |
| Enrollment | 182 (estimated) |
| Sponsor | University of Sao Paulo General Hospital Academic / other |
| Locations | 1 site (São Paulo, São Paulo) |
| Status | Recruiting |
| Started | March 24, 2026 |
| Main results expected | November 2026 |
| Study ends | November 2026 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT07489456 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women diagnosed with gestational diabetes by IADPSG criteria who delivered at HC-FMUSP, can schedule a 75g OGTT 6–12 weeks after delivery, and provide informed consent are eligible.
✕Probably not a fit
Women who withdraw consent, cannot receive or respond to WhatsApp messages, or who cannot complete the OGTT (for example due to vomiting) are unlikely to benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Women diagnosed with gestational diabetes at the University of Sao Paulo General Hospital will be scheduled for a 75g oral glucose tolerance test between six and 12 weeks after delivery. The intervention uses WhatsApp reminders to try to increase attendance for the OGTT compared with usual care. During the OGTT the team will record fasting, 1-hour, and 2-hour glucose values to compare how often the 1-hour versus 2-hour measurements identify dysglycemia. Data will be analyzed to quantify any change in attendance and the relative detection rates of postpartum dysglycemia using the different time points.
Why it matters
Potential benefit: If successful, this approach could increase postpartum OGTT attendance and lead to earlier detection of prediabetes or type 2 diabetes after gestational diabetes.
How similar studies have gone: Previous research has shown electronic reminders can improve clinic attendance and some studies suggest the 1-hour OGTT glucose may be more sensitive than the 2-hour value for early postpartum dysglycemia, so this project builds on existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of gestational diabetes mellitus, according to diagnostic criteria proposed by the IADPSG, namely: * initial fasting blood glucose ≥ 92mg/dL OR * 75g oral glucose tolerance test with fasting ≥ 92mg/dL or after 1h ≥ 180mg/dL or after 2h ≥ 153mg/dL Delivery performed at HC-FMUSP Scheduling of the 75g oral glucose tolerance test between 6 and 12 weeks after delivery Agreement with the informed consent form Exclusion Criteria: Withdrawal of consent Failure to complete the TOTG exam due to vomiting (exclusion from analysis 2 only)
Where it's running
-
University of Sao Paulo General Hospital
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Study coordinator: Tatiana A Zaccara, MD PhD
- Email: tatiana.assuncao@hc.fm.usp.br
- Phone: +551126616209
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Metformin vs glyburide for blood sugar in gestational diabetes
This study tests whether metformin or glyburide better controls blood sugar in pregnant women with gestational diabetes who need oral medication.
-
Quality of life and psychological factors in women with gestational diabetes
This study tests how gestational diabetes affects quality of life and stress or anxiety in pregnant women treated at a hospital in Ludhiana.
-
Myo-Inositol for Glycemic Control in Gestational Diabetes
This study tests whether taking myo-inositol with folic acid can improve blood sugar control and reduce inflammation in pregnant people with gestational diabetes.
-
Daily kefir during mid-pregnancy to see if it helps prevent gestational diabetes
Pregnant people will drink kefir daily from mid-pregnancy to see if it improves blood sugar and insulin, reduces gestational diabetes risk, and positively affects gut bacteria.
-
Protective effect of lactation on gestational diabetes in a future pregnancy
This observational study tests whether lactation around the time of a first pregnancy is linked to a lower risk of gestational diabetes in a subsequent pregnancy for women who conceive while lactating.
-
Natural cervical ripening to delay pharmacological induction of labor
This pilot study tests whether nipple stimulation and membrane sweeping can help some pregnant people go into labor on their own without needing drugs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.